Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2014-05-31

Study Completion Date

2015-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Compare anticapsular antibody levels against Group B Streptococcus at delivery in mothers and their infants who develop disease versus those who do not. Use this comparison to establish antibody levels associated with reductions in risk of GBS disease in infants aged less than 90 days.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

GBS Sero-correlate of Protection

NCT02215226

Invasive Group B Streptococcus Disease

COMPLETED

Group B Strep Correlates of Protection Study

NCT06431217

Maternal Health Child Health Infectious Diseases

COMPLETED

Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])

NCT01888471

Streptococcus Agalactiae

COMPLETED NA

Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus Disease

NCT04735419

Streptococcus Agalactiae Infection

RECRUITING

Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings

NCT01412801

Streptococcal Infections Gram-Positive Bacterial Infections Bacterial Infections

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Invasive Group B Streptococcus Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Controls

Infants born to GBS colonized mother who do not develop GBS disease

No interventions assigned to this group

Cases

Infants with culture confirmed GBS disease

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women attending participating community/hospital antenatal clinics and/or delivering at participating delivery centers.
* Subjects aged ≥18 years.
* Able to understand and comply with planned study procedures.
* Provides written informed consent.